Winton Group LTD Amneal Pharmaceuticals, Inc. Transaction History

Winton Group LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$2.76 - $4.59 $90,677 - $150,799	32,854 Added 172.3%	51,922 $219,000
Q2 2023 Aug 14, 2023	BUY	$1.33 - $3.1 $25,360 - $59,110	19,068 New	19,068 $59,000
Q3 2021 Oct 28, 2021	SELL	$4.31 - $5.64 $58,150 - $76,094	-13,492 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$5.12 - $6.82 $4,894 - $6,519	956 Added 7.63%	13,492 $69,000
Q1 2021 Jul 21, 2021	BUY	$4.74 - $7.38 $59,420 - $92,515	12,536 New	12,536 $84,000
Q4 2020 Feb 12, 2021	SELL	$3.95 - $5.42 $126,676 - $173,819	-32,070 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$3.54 - $5.27 $113,527 - $169,008	32,070 New	32,070 $124,000
Q1 2020 May 11, 2020	SELL	$2.46 - $5.35 $55,913 - $121,600	-22,729 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.65 - $5.56 $60,231 - $126,373	22,729 New	22,729 $110,000

189

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.31B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.